FDA 202008Orig1s000, summary review for regulatory action, F18-florbetapir. CENTER FOR DRUG EVALUATION AND RESEARCH
Recommends
Please login to recommend the paper.
FDA 202008Orig1s000, summary review for regulatory action, F18-florbetapir. CENTER FOR DRUG EVALUATION AND RESEARCH
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.